Safety of intraoperative autologous blood transfusion combined with leukocyte filter in pediatric intracranial tumors surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023764

Enrollment

Unknown

Registered

2019-06-11

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial tumor

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with intracranial tumors diagnosed by craniocerebral surgery in Guangzhou Women and Children Medical Center who underwent selective tumor resection and used blood recycling machine during operation. Selection criteria: 1) The expected blood loss is more than 15% of the estimated maximum blood volume of the child; 2) No cross matching can be obtained, and the family members of the children are unwilling to accept allogeneic blood, but willing to accept intraoperative autologous blood transfusion; 3) Rare blood group.

Exclusion criteria

Exclusion criteria: 1) Hemolysis of red blood cells; 2) Family members refused to use the technology; 3) sepsis or sepsis; 4) The tumors have metastasis or recurrence.

Design outcomes

Primary

Measure	Time frame
Tumor cells in blood;	—

Countries

China

Contacts

Public ContactNa Zhang

Guangzhou Women and Children's Medical Center

na999666@163.com+86 13560409867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026